Article Information
History
- March 29, 2021.
Article Versions
- Version 1 (December 4, 2020 - 08:19).
- Version 2 (December 4, 2020 - 12:36).
- Version 3 (December 5, 2020 - 02:55).
- Version 4 (December 5, 2020 - 18:48).
- You are viewing Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Joshua M. Wang1,
- Wenke Liu1,
- Xiaoshan Chen2,
- Michael P. McRae3,
- John T. McDevitt3 and
- David Fenyö1,*
- 1Institute for Systems Genetics; Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY, 10016, USA
- 2Department of Medicine, NYU Grossman School of Medicine, New York, NY, 10016, USA
- 3Department of Biomaterials, Bioengineering Institute, New York University College of Dentistry, New York, NY, United States
- ↵*Corresponding author; email: David.Fenyo{at}nyulangone.org
Competing Interests: MPM has served as a paid consultant for SensoDx, LLC and has a provisional patent pending. JTM has a provisional patent pending. In addition, he has an ownership position and an equity interest in both SensoDx, LLC and OraLiva, Inc. and serves on their advisory boards. All other authors declare no competing interests.
Posted March 29, 2021.
Predictive modeling of morbidity and mortality in COVID-19 hospitalized patients and its clinical implications
